PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 47 filers reported holding PANACEA ACQUISITION CORP II in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,180,000 | +101392.5% | 900,000 | 0.0% | 2.78% | -22.9% |
| Q4 2022 | $9,045 | -99.9% | 900,000 | 0.0% | 3.60% | -93.1% |
| Q3 2022 | $8,820,000 | +0.4% | 900,000 | 0.0% | 51.96% | +707.5% |
| Q2 2022 | $8,784,000 | +0.2% | 900,000 | 0.0% | 6.43% | +76.7% |
| Q1 2022 | $8,766,000 | +0.5% | 900,000 | 0.0% | 3.64% | +17.9% |
| Q4 2021 | $8,721,000 | -0.6% | 900,000 | 0.0% | 3.09% | -9.8% |
| Q3 2021 | $8,775,000 | -2.5% | 900,000 | 0.0% | 3.42% | +12.8% |
| Q2 2021 | $9,000,000 | – | 900,000 | – | 3.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIT CAPITAL PARTNERS PLC | 900,000 | $9,000,000 | 3.04% |
| MYDA Advisors LLC | 600,000 | $6,009,000 | 1.50% |
| Sage Rock Capital Management LP | 382,500 | $3,831,000 | 0.50% |
| 683 Capital Management, LLC | 1,400,000 | $14,022,000 | 0.48% |
| Bain Capital Life Sciences Investors, LLC | 500,000 | $5,010,000 | 0.33% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 886,642 | $8,866,000 | 0.25% |
| Consonance Capital Management LP | 200,000 | $2,002,000 | 0.24% |
| Governors Lane LP | 250,000 | $2,504,000 | 0.18% |
| Boxer Capital, LLC | 500,000 | $5,010,000 | 0.18% |
| Greenlight Capital | 275,000 | $2,754,000 | 0.17% |